Skip to main content
Steven Libutti, MD, General Surgery, New Brunswick, NJ, Robert Wood Johnson University Hospital

StevenKennethLibuttiMD

General Surgery New Brunswick, NJ

Endocrine, Surgical Oncology (Other than Breast)

Director, Rutgers Cancer Institute of New Jersey, Vice Chancellor Cancer Programs, Rutgers Biomedical and Health Sciences, Senior Vice President Oncology Services, RWJBarnabas Health

Dr. Libutti is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Libutti's full profile

Already have an account?

Education & Training

  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Endocrine Surgery, 1995 - 1996
  • New York Presbyterian Hospital
    New York Presbyterian HospitalResidency, Surgery, 1990 - 1995
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1990, MD, Alpha Omega Alpha
  • Harvard College
    Harvard CollegeAB, Biology, Magna Cum Laude, 1982 - 1986

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2017 - 2023
  • NY State Medical License
    NY State Medical License 1992 - 2023
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • PheoPara Alliance Science Award 2012
  • Top Doctors New York Metro Area 2010-2013
  • America's Top Doctors 2010-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Comparison of Bethesda Cytopathology Classification to Surgical Pathology Across Racial‐Ethnic Groups  
    Bradley A Schiff, Steven K Libutti, Thomas J Ow, Richard V Smith, Juan Lin, Vikas Mehta, Amanda M Laird, Head & Neck
  • Minimally Invasive Surgery for Pancreatic Neuroendocrine Tumors Results in Shorter Length of Stay  
    Amanda M Laird, John C Mcauliffe, Steven K Libutti, Journal of The American College of Surgeons
  • Interferon Alpha Triggers Autoimmune Thyroid Diseases via Lysosomal-Dependent Degradation of Thyroglobulin  
    Steven K Libutti, Yaron Tomer, The Journal of Clinical Endocrinology and Metabolism
  • Join now to see all

Authored Content

  • My Favorite Sessions from AACR's 2021 Virtual MeetingApril 2021
  • Minimally Invasive Surgery for Pancreatic Neuroendocrine Tumors Results in Shorter Length of StayOctober 2018
  • Surface-Modified Shortwave-Infrared-Emitting Nanophotonic Reporters for Gene-Therapy ApplicationsApril 2018

Press Mentions

  • Aretha Franklin's Death Raises Awareness Around Endocrine Cancer, Treatment Options
    Aretha Franklin's Death Raises Awareness Around Endocrine Cancer, Treatment OptionsAugust 17th, 2018
  • Scientific and Clinical PLGA Progress: Indebted to the Founding PLGA Scientific Advisors
    Scientific and Clinical PLGA Progress: Indebted to the Founding PLGA Scientific AdvisorsJune 4th, 2018
  • NETRF Funds $3.5 Million in Research to Advance Neuroendocrine Tumor Treatment
    NETRF Funds $3.5 Million in Research to Advance Neuroendocrine Tumor TreatmentFebruary 14th, 2020
  • Join now to see all

Grant Support

  • Ruth L. Kirschstein T32 Training GrantNational Cancer Institute2015–2020
  • Deciphering the tissue specificity of MEN1 related tumorigenesisNational Cancer Institute2012–2017
  • Multifunctional Nanoassemblies for Ligand Directed TherapyNational Cancer Institute2014–2016
  • Targeting The Tumor Vasculature To Treat CancerNational Cancer Institute2007–2008
  • Targeting The Tumor Vasculature To Treat CancerDivision Of Clinical Sciences - Nci2001–2006

Professional Memberships

Hospital Affiliations